BidaskClub upgraded shares of Catalent Inc (NASDAQ:CTLT) from a hold rating to a buy rating in a research report sent to investors on Thursday morning.
Several other analysts also recently weighed in on CTLT. Zacks Investment Research upgraded Catalent from a sell rating to a buy rating and set a $39.00 price objective for the company in a research report on Tuesday, July 4th. Bank of America Corporation reiterated a buy rating and issued a $38.00 price objective (up previously from $37.00) on shares of Catalent in a research report on Friday, July 21st. Piper Jaffray Companies reiterated a buy rating and issued a $45.00 price objective on shares of Catalent in a research report on Tuesday, August 29th. J P Morgan Chase & Co reiterated a buy rating and issued a $40.00 price objective on shares of Catalent in a research report on Tuesday, August 29th. Finally, Jefferies Group LLC reiterated a hold rating and issued a $38.00 price objective (up previously from $35.00) on shares of Catalent in a research report on Tuesday, August 29th. Five analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Catalent has a consensus rating of Buy and a consensus price target of $38.64.
Catalent (CTLT) traded up 0.83% during mid-day trading on Thursday, reaching $42.29. 1,359,781 shares of the company’s stock were exchanged. Catalent has a one year low of $21.83 and a one year high of $42.63. The stock has a 50-day moving average of $39.48 and a 200-day moving average of $34.78. The stock has a market cap of $5.29 billion and a price-to-earnings ratio of 48.61.
Catalent (NASDAQ:CTLT) last released its earnings results on Monday, August 28th. The company reported $0.65 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.57 by $0.08. Catalent had a return on equity of 36.29% and a net margin of 10.02%. The company had revenue of $616.90 million during the quarter, compared to the consensus estimate of $547.48 million. During the same quarter in the previous year, the company posted $0.52 EPS. Catalent’s quarterly revenue was up 15.9% compared to the same quarter last year. On average, equities research analysts anticipate that Catalent will post $1.62 earnings per share for the current year.
TRADEMARK VIOLATION WARNING: This piece of content was first reported by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://transcriptdaily.com/2017/10/08/catalent-inc-ctlt-raised-to-buy-at-bidaskclub.html.
In related news, SVP Christine Dolan sold 745 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $34.85, for a total transaction of $25,963.25. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Several institutional investors have recently made changes to their positions in CTLT. Strs Ohio raised its holdings in shares of Catalent by 16.5% during the first quarter. Strs Ohio now owns 9,900 shares of the company’s stock valued at $280,000 after acquiring an additional 1,400 shares in the last quarter. Russell Investments Group Ltd. raised its holdings in shares of Catalent by 31.0% during the first quarter. Russell Investments Group Ltd. now owns 20,891 shares of the company’s stock valued at $591,000 after acquiring an additional 4,943 shares in the last quarter. Karp Capital Management Corp bought a new position in shares of Catalent during the first quarter valued at approximately $648,000. Parametric Portfolio Associates LLC raised its holdings in shares of Catalent by 12.3% during the first quarter. Parametric Portfolio Associates LLC now owns 153,781 shares of the company’s stock valued at $4,355,000 after acquiring an additional 16,856 shares in the last quarter. Finally, Virginia Retirement Systems ET AL bought a new position in shares of Catalent during the first quarter valued at approximately $326,000.
Catalent, Inc provides delivery technologies and development solutions for drugs, biologics, and consumer and animal health products. Its segments include Softgel Technologies, Drug Delivery Solutions and Clinical Supply Services. The Softgel Technologies segment is engaged in the formulation, development and manufacturing of prescription and consumer health soft capsules or softgels.
Receive News & Ratings for Catalent Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catalent Inc and related companies with MarketBeat.com's FREE daily email newsletter.